• Wed, May 15, 2024
Arthur He Reiterated (BCAB) at Strong Buy and Held Target at $7 on, May 15th, 2024
Arthur He of HC Wainwright & Co., Reiterated "BioAtla, Inc." (BCAB) at Strong Buy and Held Target at $7 on, May 15th, 2024.
Arthur has made no other calls on BCAB in the last 4 months.
There is 1 other peer that has a rating on BCAB. Out of the 1 peers that are also analyzing BCAB, 0 agree with Arthur's Rating of Hold.
This is the rating of the analyst that currently disagrees with Arthur
- Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $12 on, Thursday, March 28th, 2024